异常的2型多巴胺受体在精神病态的暴力犯罪者中的可用性
Lasse Lukkarinen1, Jouni Tuisku2, Lihua Sun2
1Turku PET Centre, University of Turku, Finland; Psychiatric Hospital for Prisoners, University of Turku, Finland.
NeuroImage
|July 6, 2024
概括
这项研究发现,精神病患者的大脑中多巴胺D2受体的可用性较低. 这表明多巴胺D2受体信号传递可能在精神病的神经生物学中发挥关键作用.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 分子生物学分子生物学
背景情况:
- 精神病是一种人格障碍,其特点是反社会行为,冲动和缺乏同情心.
- 心理病背后的精确分子大脑机制尚未得到充分理解.
- 以前的研究表明神经递质系统的潜在变化.
研究的目的:
- 调查2型多巴胺受体 (D2R) 和片受体 (MOR) 在具有高度精神病态特征的个体大脑中的可用性.
- 探索精神病特征与这些受体的可用性之间的关系.
主要方法:
- 使用正子发射断层扫描 (PET) 来测量D2R和MOR可用性.
- 使用了放射性分子[11C]拉克洛普里德 (用于D2R) 和[11C]卡尔芬坦尼尔 (用于MOR).
- 这项研究包括了被定罪的暴力犯罪者,具有高度的精神病特征和健康的对照.
主要成果:
- 患有精神病症的个体在尾状和状骨中显示D2R可用性降低.
- 状D2R可用性与囚犯组中精神病特征的严重程度相关.
- 没有观察到MOR可用性的显著群体差异,尽管在特定的大脑区域发现了与精神病特征的相关性.
结论:
- 多巴胺D2受体信号传递被认为是一种潜在的神经分子通路,有助于精神病变.
- 根据这项研究的发现,mu-阿片类受体系统在精神病中的作用似乎不那么突出.
更多相关视频
相关概念视频
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
564
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
564
Antisocial Personality Disorder
46
Antisocial personality disorder is a chronic mental health condition characterized by persistent patterns of disregard for the rights and well-being of others. Individuals with antisocial personality disorder exhibit behaviors that include deceitfulness, impulsivity, irresponsibility, aggression, and a profound lack of empathy. These traits often manifest early in life and persist into adulthood, leading to significant personal, social, and legal consequences.
Behavioral Characteristics and...
Behavioral Characteristics and...
46
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Drug Abuse and Addiction: Pharmacological Phenomena
463
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
463
Antipsychotic Drugs: Typical and Atypical Agents
175
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
175
Adrenergic Agonists: Indirect-Acting Agents
1.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K


